Feed/Investors/Velosity Capital

Velosity Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-07-15

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$315M

across 1 round

LATEST ROUND

Series D · $315M · 2026-07-15

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer.	Series D Verified against 4 of 6 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts.	$315M	2026-07-15	[ PART ]